ifosfamide has been researched along with Lymphoma, B-Cell, Marginal Zone in 2 studies
Lymphoma, B-Cell, Marginal Zone: Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire mucosa-associated lymphoid tissue (MALT) type as a result of an immunologically mediated disorder.
Excerpt | Relevance | Reference |
---|---|---|
"First relapse was treated with high-dose BEAM chemotherapy and autologous peripheral blood stem cell transplantation (PBSCT)." | 1.30 | Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation. ( Behringer, D; Fetscher, S; Finke, J; Kanz, L; Lange, W; Lübbert, M; Mertelsmann, R, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fetscher, S | 1 |
Lübbert, M | 1 |
Kanz, L | 1 |
Behringer, D | 1 |
Finke, J | 1 |
Mertelsmann, R | 1 |
Lange, W | 1 |
Naya, Y | 1 |
Ohe, M | 1 |
Fujino, M | 1 |
Akiyama, Y | 1 |
Kirisawa, T | 1 |
Kawakami, Y | 1 |
2 other studies available for ifosfamide and Lymphoma, B-Cell, Marginal Zone
Article | Year |
---|---|
Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Ther | 1997 |
[A case of primary endobronchial mucosa-associated lymphoid tissue lymphoma with middle lobe atelectasis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; | 1997 |